4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline
    Journal Article

    Chang, S. S.; Bochner, B. H.; Chou, R.; Dreicer, R.; Kamat, A. M.; Lerner, S. P.; Lotan, Y.; Meeks, J. J.; Michalski, J. M.; Morgan, T. M.; more...
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • High demoralization in a minority of oophorectomized BRCA1/2 mutation carriers influences quality of life
    Meeting Abstract

    Arts-De Jong, M.; De Jong, C.; Hermens, R.; Kissane, D.; Massuger, L.; Hoogerbrugge, N.; Prins, J.; de Hullu, J. A.
    Psycho-Oncology (2017)

    Fulltext@MSK | Save
  • The hypothalamic-pituitary-adrenal axis in health and disease: Cushing’s syndrome and beyond
    Book Whole


    Springer (2017)

    Fulltext@MSK | Save
  • Meaning centered psychotherapy training for cancer care providers
    Meeting Abstract

    Breitbart, W.; Duhamel, K.
    Psycho-Oncology (2017)

    Fulltext@MSK | Save
  • Anti-CTLA-4 checkpoint inhibitormediated anticancer immunity relies on tumor-intrinsic RIG-I signaling
    Meeting Abstract

    Heidegger, S.; Wintges, A.; Bek, S.; Schmickl, M.; Steiger, K.; Koenig, P. A.; Ruland, J.; van den Brink, M. R. M.; Peschel, C.; Haas, T.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Nivolumab ± ipilimumab in patients (pts) with advanced (adv) / metastatic chemotherapy-refractory (CTx-R) gastric (G), esophageal (E), or gastroesophageal junction (GEJ) cancer: CheckMate 032 study
    Meeting Abstract

    Jaeger, D.; Janjigian, Y. Y.; Ott, P. A.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Peltola, K.; Evans, J.; de Braud, F.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Evaluation of nivolumab (nivo) alone and in combination with ipilimumab (ipi) in patients (pts) with advanced (adv) small-cell lung cancer (SCLC): First report of a randomized expansion cohort from the CheckMate 032 trial
    Meeting Abstract

    Atmaca, A.; Hellmann, M. D.; Ott, P. A.; Zugazagoitia, J.; Ready, N.; Hann, C. L.; De Braud, F.; Antonia, S.; Ascierto, P.; Moreno, V.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Atezolizumab as 1L therapy for advanced NSCLC in PD-L1-selected patients: Updated ORR, PFS and OS data from the BIRCH study
    Meeting Abstract

    Eberhardt, W. E. E.; Garassino, M. C.; Rizvi, N. A.; Jänne, P. A.; Christoph, D.; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Tumor mutation burden (TMB) is associated with improved efficacy of atezolizumab in 1L and 2L+ NSCLC patients
    Meeting Abstract

    Griesinger, F.; Kowanetz, M.; Zou, W.; Shames, D. S.; Cummings, C. A.; Rizvi, N. A.; Spira, A.; Frampton, G.; Leveque, V.; Flynn, S.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save
  • Nivolumab for relapsed/refractory classical Hodgkin lymphoma after autologous transplantation: Full results after extended follow-up of the multicohort, multicenter phase 2 CheckMate 205 trial
    Meeting Abstract

    Jäger, U.; Engert, A.; Fanale, M.; Santoro, A.; Armand, P.; Ansell, S.; Zinzani, P. L.; Timmerman, J. M.; Collins, G. P.; Ramchandren, R.; more...
    Oncology Research and Treatment (2017)

    Fulltext@MSK | Save